- Home
- THTX
as 07-26-2024 4:00pm EST
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.
| Founded: | 1993 | Country: | Canada |
| Employees: | N/A | City: | N/A |
| Market Cap: | 59.3M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 58.0K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.10 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.88 - $3.29 | Next Earning Date: | 07-10-2024 |
| Revenue: | $60,713,971 | Revenue Growth: | 3.62% |
| Revenue Growth (this year): | 10.71% | Revenue Growth (next year): | 12.74% |
Latest Theratechnologies Inc. News
THTX Breaking Stock News: Dive into THTX Ticker-Specific Updates for Smart Investing
Simply Wall St.
10 days ago
Theratechnologies Second Quarter 2024 Earnings: Beats Expectations
Zacks
10 days ago
Despite Fast-paced Momentum, Theratechnologies (THTX) Is Still a Bargain Stock
Benzinga
16 days ago
HIV Medicine Maker Theratechnologies 'Wraps Up Strong Second Quarter,' Stock Soars
Associated Press Finance
16 days ago
Theratechnologies: Fiscal Q2 Earnings Snapshot
MT Newswires
17 days ago
Theratechnologies Swings to Q2 Profit as Revenue Rises 25%; Confirms FY24 Guidance
GlobeNewswire
17 days ago
Theratechnologies Reports Financial Results and Announces Positive Net Income for Second Quarter 2024
GlobeNewswire
a month ago
Theratechnologies to Announce Second Quarter 2024 Financial Results and Provide Business Update
Simply Wall St.
a month ago
Theratechnologies Inc. (TSE:TH) Has Found A Path To Profitability
Compare THTX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "THTX Theratechnologies Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.